文献速递前列腺癌

乙酰唑胺对机器人辅助腹腔镜前列腺切除术围手术期疼痛控制的影响

Impact of Acetazolamide on Perioperative Pain Control in Robotic Assisted Laparoscopic Prostatectomy.
PubMed 文献 · Urology · 2022-12-05

本研究将接受机器人辅助腹腔镜前列腺切除术(RALP)的患者随机分为术前给予生理盐水或乙酰唑胺两组,比较术后多个时间点总体疼痛评分及吗啡总当量。结果显示两组疼痛评分及吗啡总当量均无显著差异,乙酰唑胺似乎不影响RALP患者的总体疼痛或肩尖痛。

要点

  • 共31例患者纳入研究,16例(51.6%)接受乙酰唑胺,15例(48.4%)接受生理盐水安慰剂。
  • 两组在各时间点总体疼痛评分相似,差异均无统计学显著性。
  • 两组均无肩尖痛发生,吗啡总当量无显著差异。

核心结论

  • 乙酰唑胺似乎不影响接受RALP患者的总体疼痛或肩尖痛。

研究设计与样本

  • 随机对照研究,将接受RALP的患者随机分为术前给予生理盐水或乙酰唑胺两组,共纳入31例患者:16例(51.6%)接受乙酰唑胺,15例(48.4%)接受生理盐水安慰剂。

主要发现

  • 总体疼痛评分在首次应答时乙酰唑胺组为3.5 ± 3.1 vs 安慰剂组4.1 ± 1.7(P = .28)。
  • 离开PACU前即刻疼痛评分乙酰唑胺组为2.8 ± 2.9 vs 安慰剂组2.9 ± 2.9(P = .48)。
  • 术后4小时疼痛评分乙酰唑胺组为3.1 ± 3.0 vs 安慰剂组2.9 ± 1.8(P = .362)。
  • 术后24小时疼痛评分乙酰唑胺组为2.3 ± 1.7 vs 安慰剂组2.2 ± 1.6(P = .5)。
  • 两组均无肩尖痛发生;吗啡总当量乙酰唑胺组为17.3 vs 安慰剂组20.5(P = .2)。

临床怎么用

  • 作者认为,乙酰唑胺似乎不影响接受RALP患者的总体疼痛或肩尖痛。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the efficacy of peri-operative acetazolamide for pain control in robotic assisted laparoscopic prostatectomy (RALP). Prior studies have demonstrated that preoperative acetazolamide decreased postoperative referred pain in the postsurgical period for laparoscopic procedures. The proposed mechanism is acetazolamide mediated inhibition of carbonic anhydrase, thereby preventing formation of carbonic acid and subsequent peritoneal acidosis with referred pain. This has yet to be demonstrated in the setting of RALP. METHODS AND MATERIALS: Patients undergoing RALP were randomized to receive either preoperative saline or acetazolamide prior to the procedure. Overall pain scores were recorded at multiple time points post operatively, as well as total morphine equivalents administered for adjunctive pain control. RESULTS: Thirty-one patients were included in the study: 16 patients (51.6%) received perioperative acetazolamide, and 15 patients (48.4%) received perioperative saline as placebo. Overall pain scores were similar for patients receiving acetazolamide compared to placebo at various time points: first responsive (3.5 ± 3.1 vs 4.1 ± 1.7, P = .28), immediately prior to leaving PACU (2.8 ± 2.9 vs 2.9 ± 2.9, P = .48), at 4 hours post-procedure (3.1 ± 3.0 vs 2.9 ± 1.8, P = .362), or at 24 hours post-procedure (2.3 ± 1.7 vs 2.2 ± 1.6, P = .5). Shoulder tip pain was not present in either cohort. No statistically significant difference was observed for total morphine equivalents delivered between acetazolamide and placebo (17.3 vs 20.5, P= .2, respectively). CONCLUSION: Acetazolamide does not appear to impact overall pain or shoulder tip pain in the observed cohort of patients undergoing RALP.

来源:Urology,查看原文。版权归原作者所有。

引用

  1. Medairos R, Lankford J, Everett R, et al. Impact of Acetazolamide on Perioperative Pain Control in Robotic Assisted Laparoscopic Prostatectomy. Urology. 2022. PMID: 36481203. doi:10.1016/j.urology.2022.11.014

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。